Poster 54
- Kelley Tangredi
- Apr 26, 2024
- 1 min read
Updated: Jun 27, 2024
Dupilumab Demonstrates Higher Likelihood of Achieving Improvements in Signs, Symptoms, and Quality of Life Vs Lebrikizumab: Results From A Placebo-adjusted Indirect Comparison Analysis
Authors: Patricia Guyot, Yingxin Xu, Amy Praestgaard, Nick Freemantle, Ana B. Rossi, Brad Shumel, Gaelle Bego Le Bagousse, Zhixiao Wang, Kerry Noonan, Mike Bastian
Poster 54